European Malignant Hyperthermia Group 2025 guidelines revise investigation of MH susceptibility: they add an MH genotype designation from DNA testing alongside the in vitro halothane/caffeine contracture test, and first consensus definition of a clinical MH event.
Guideline
Rüffert et al. European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility